LeadIQ logo
Learn more at LeadIQ.com

Insights

Acquisition Opportunities LogicBio Therapeutics has been recently acquired by Alexion Pharmaceuticals and AstraZeneca Rare Disease, presenting opportunities for cross-selling genetic medicines developed by the company within the larger network.

Gene Therapy Focus With a focus on gene editing technology like GeneRide™, LogicBio Therapeutics offers innovative solutions for rare pediatric diseases, opening doors for partnerships with healthcare institutions seeking advanced genetic therapies.

Partnering in Platform Development LogicBio Therapeutics is collaborating with companies like Exothera SA for the development of scalable AAV manufacturing platforms, making it an ideal partner for biotech firms seeking to enhance their gene therapy capabilities.

Market Positioning Strategy As LogicBio Therapeutics is positioned within the biotechnology research industry alongside key players like Beam Therapeutics and Editas Medicine, exploring strategic collaborations or joint ventures could lead to synergistic market positioning opportunities.

Focused Investment Ventures Given LogicBio Therapeutics' revenue range of $10M - 50M and technology-driven approach to genetic medicines, investing in the company or exploring funding partnerships could provide avenues for growth and business expansion.

Similar companies to LogicBio Therapeutics

LogicBio Therapeutics Tech Stack

LogicBio Therapeutics uses 8 technology products and services including Twitter Emoji (Twemoji), Google Font API, Modernizr, and more. Explore LogicBio Therapeutics's tech stack below.

  • Twitter Emoji (Twemoji)
    Font Scripts
  • Google Font API
    Font Scripts
  • Modernizr
    Javascript Libraries
  • MobX
    Javascript Libraries
  • FancyBox
    Javascript Libraries
  • MyWebsite Creator
    Page Builders
  • MyWebsite
    Page Builders
  • Bootstrap
    UI Frameworks

Media & News

LogicBio Therapeutics's Email Address Formats

LogicBio Therapeutics uses at least 1 format(s):
LogicBio Therapeutics Email FormatsExamplePercentage
FLast@logicbio.comJDoe@logicbio.com
50%
FLast@logicbio.comJDoe@logicbio.com
50%

Frequently Asked Questions

Where is LogicBio Therapeutics's headquarters located?

Minus sign iconPlus sign icon
LogicBio Therapeutics's main headquarters is located at 65 Hayden Ave Lexington, Massachusetts 02421 US. The company has employees across 3 continents, including North AmericaAsiaEurope.

What is LogicBio Therapeutics's phone number?

Minus sign iconPlus sign icon
You can contact LogicBio Therapeutics's main corporate office by phone at +1-617-245-0399. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is LogicBio Therapeutics's stock symbol?

Minus sign iconPlus sign icon
LogicBio Therapeutics is a publicly traded company; the company's stock symbol is LOGC2.

What is LogicBio Therapeutics's official website and social media links?

Minus sign iconPlus sign icon
LogicBio Therapeutics's official website is logicbio.com and has social profiles on LinkedIn.

How much revenue does LogicBio Therapeutics generate?

Minus sign iconPlus sign icon
As of September 2024, LogicBio Therapeutics's annual revenue reached $15M.

What is LogicBio Therapeutics's SIC code NAICS code?

Minus sign iconPlus sign icon
LogicBio Therapeutics's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does LogicBio Therapeutics have currently?

Minus sign iconPlus sign icon
As of September 2024, LogicBio Therapeutics has approximately 51 employees across 3 continents, including North AmericaAsiaEurope. Key team members include Executive Assistant To Chief Executive Officer: S. N.Principal Scientist And Program Lead: A. B.Vivarium And Lab Operations Manager: V. M.. Explore LogicBio Therapeutics's employee directory with LeadIQ.

What industry does LogicBio Therapeutics belong to?

Minus sign iconPlus sign icon
LogicBio Therapeutics operates in the Biotechnology Research industry.

What technology does LogicBio Therapeutics use?

Minus sign iconPlus sign icon
LogicBio Therapeutics's tech stack includes Twitter Emoji (Twemoji)Google Font APIModernizrMobXFancyBoxMyWebsite CreatorMyWebsiteBootstrap.

What is LogicBio Therapeutics's email format?

Minus sign iconPlus sign icon
LogicBio Therapeutics's email format typically follows the pattern of . Find more LogicBio Therapeutics email formats with LeadIQ.
LogicBio Therapeutics

LogicBio Therapeutics

Biotechnology ResearchMassachusetts, United States51-200 Employees

We are a genome editing company developing genetic medicines for the fight against rare pediatric diseases.

GeneRide™ is a promoterless and nuclease-free approach to gene insertion which may improve the safety profile of AAV based gene therapies

With GeneRide™, the therapeutic gene is site-specifically integrated into the genome allowing durable gene expression in dividing cells and mature tissues. Furthermore, therapeutic gene expression is regulated by the targeted locus so production can be limited to specific cell types.

LogicBio has been acquired by Alexion, AstraZeneca Rare Disease. For future updates on our genome editing program, follow Alexion Pharmaceuticals.

Section iconCompany Overview

Headquarters
65 Hayden Ave Lexington, Massachusetts 02421 US
Phone number
+1-617-245-0399
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
LOGC2
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconFunding & Financials

  • $10M$50M

    LogicBio Therapeutics's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $10M$50M

    LogicBio Therapeutics's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.